- ASSISTANT PROFESSOR Medicine, Cardiology
- Atrial Fibrillation
- Atrial Flutter
- Automatic Cardioverter Defibrillator Implantation
- Cardiac Stress Test
- Coronary Artery Disease
- Heart Attack
- Heart Murmur
- High Blood Pressure
- High Cholesterol
- Mitral Valve Prolapse
- Pacemaker Insertion
- Paroxysmal Supraventricular Tachycardia
- Radiofrequency Ablation
- Ventricular Tachycardia
- Wolff-Parkinson-White Syndrome
MD, Athens University School of Medicine
Residency, Internal Medicine
St. Johns Episcopal Hospital
Constantine E. Kosmas, M.D., Ph.D., FACC, FACP is an Assistant Professor of Medicine at the Mount Sinai School of Medicine and Medical Director of Mount Sinai Advanced Cardiovascular Group in Astoria, New York. He was born in Athens, Greece. He graduated with "Excellent" from the University of Athens Medical School, Athens, Greece and he was also granted a doctorate (Ph.D.) by the University of Athens Medical School. The title of his doctoral thesis was: "Substitution of the left and right ventricles by counterpulsation pumps during ventricular fibrillation. Mechanism of the hemodynamic effect of the right ventricular pump".
He completed his residency in Internal Medicine at St. John's Episcopal Hospital, Far Rockaway, NY and his fellowship in Cardiology at Episcopal Hospital, Philadelphia, PA.
Before joining the Faculty of Mount Sinai, he has been Clinical Assistant Professor of Medicine at the Medical School of the University of Pennsylvania and at the Weill Medical College of Cornell University. Dr. Kosmas has also served as Director of Clinical Services and Associate Director of Nuclear Cardiology at Episcopal Hospital, Philadelphia, PA, as well as Acting Director of Coronary Care Unit at New York Hospital Queens, Flushing, New York.
Dr. Kosmas holds Board Certifications in Cardiovascular Disease, Nuclear Cardiology and Clinical Lipidology. He has also been extensively involved in cardiovascular research with several publications in the medical literature.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Kosmas did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.